Dysregulated expression of MIC-1/PDF in human prostate tumor cells

Biochemical and Biophysical Research Communications

Volumn 305, Issue 3, 2003, Pages 598-604

  Karan, Dev ^a   Chen, Siu Ju ^a   Johansson, Sonny L ^a,b   Singh, Ajay P ^a   Paralkar, Vishwas M ^c   Lin, Ming Fong ^a,b   Batra, Surinder K ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c PFIZER INC   (United States)

Author keywords

Immunohistochemistry; LNCaP cell model; MIC 1 PDF; Prostate cancer

Indexed keywords

ANDROGEN;

ARTICLE; BENIGN TUMOR; CANCER CELL; COMPARATIVE STUDY; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MACROPHAGE INHIBITORY CYTOKINE 1 GENE; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE; PROSTATE ADENOCARCINOMA; PROSTATE TUMOR; SERUM FACTOR; STAINING; TUMOR CELL; TUMOR CELL CULTURE;

EID: 0038578603     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00823-4     Document Type: Article

References (28)

1. Jemal A., Thomas A., Murray T., Thun M. Cancer statistics 2002. CA Cancer J. Clin. 52:2002;23-47.
2. Sadar M.D., Hussain M., Bruchovsky N. Prostate cancer: molecular biology of early progression to androgen independence. Endocr. Relat. Cancer. 6:1999;487-502.
3. Cunha G.R., Donjacour A.A., Cooke P.S., Mee S., Bigsby R.M., Higgins S.J., Sugimura Y. The endocrinology and developmental biology of the prostate. Endocr. Rev. 8:1987;338-362.
4. Gittes R.F. Carcinoma of the prostate. N. Engl. J. Med. 324:1991;236-245.
5. Qi H., Labrie Y., Grenier J., Fournier A., Fillion C., Labrie C. Androgens induce expression of SPAK, a STE20/SPS1-related kinase, in LNCaP human prostate cancer cells. Mol. Cell Endocrinol. 182:2001;181-192.
6. Karan D., Schmied B.M., Dave B.J., Wittel U.A., Lin M.F., Batra S.K. Decreased androgen-responsive growth of human prostate cancer is associated with increased genetic alterations. Clin. Cancer Res. 7:2001;3472-3480.
7. Karan D., Kelly D.L., Rizzino A., Lin M.F., Batra S.K. Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells. Carcinogenesis. 23:2002;967-975.
8. Karan D., Lin M.F., Johansson S.L., Batra S.K. Current status of the molecular genetics of human prostatic adenocarcinomas. Int. J. Cancer. 103:2003;285-293.
9. Igawa T., Lin F.F., Lee M.S., Karan D., Batra S.K., Lin M.F. Establishment and characterization of androgen-independent human prostate cancer LNCaP cell model. Prostate. 50:2002;222-235.
10. Lin M.F., Meng T.C., Rao P.S., Chang C., Schonthal A.H., Lin F.F. Expression of human prostatic acid phosphatase correlates with androgen-stimulated cell proliferation in prostate cancer cell lines. J. Biol. Chem. 273:1998;5939-5947.
11. Bootcov M.R., Bauskin A.R., Valenzuela S.M., Moore A.G., Bansal M., He X.Y., Zhang H.P., Donnellan M., Mahler S., Pryor K., Walsh B.J., Nicholson R.C., Fairlie W.D., Por S.B., Robbins J.M., Breit S.N. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily. Proc. Natl. Acad. Sci. USA. 94:1997;11514-11519.
12. Paralkar V.M., Vail A.L., Grasser W.A., Brown T.A., Xu H., Vukicevic S., Ke H.Z., Qi H., Owen T.A., Thompson D.D. Cloning and characterization of a novel member of the transforming growth factor-β/bone morphogenetic protein family. J. Biol. Chem. 273:1998;13760-13767.
13. Welsh J.B., Sapinoso L.M., Kern S.G., Brown D.A., Liu T., Bauskin A.R., Ward R.L., Hawkins N.J., Quinn D.I., Russell P.J., Sutherland R.L., Breit S.N., Moskaluk C.A., Frierson H.F. Jr., Hampton G.M. Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proc. Natl. Acad. Sci. USA. 100:2003;3410-3415.
14. Buckhaults P., Rago C., St Croix B., Romans K.E., Saha S., Zhang L., Vogelstein B., Kinzler K.W. Secreted and cell surface genes expressed in benign and malignant colorectal tumors. Cancer Res. 61:2001;6996-7001.
15. Moore A.G., Brown D.A., Fairlie W.D., Bauskin A.R., Brown P.K., Munier M.L., Russell P.K., Salamonsen L.A., Wallace E.M., Breit S.N. The transforming growth factor-β superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women. J. Clin. Endocrinol. Metab. 85:2000;4781-4788.
16. Brown D.A., Breit S.N., Buring J., Fairlie W.D., Bauskin A.R., Liu T., Ridker P.M. Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study. Lancet. 359:2002;2159-2163.
17. Thomas R., True L.D., Lange P.H., Vessella R.L. Placental bone morphogenetic protein (PLAB) gene expression in normal, pre-malignant and malignant human prostate: relation to tumor development and progression. Int. J. Cancer. 93:2001;47-52.
18. Welsh J.B., Sapinoso L.M., Su A.I., Kern S.G., Wang-Rodriguez J., Moskaluk C.A., Frierson H.F. Jr., Hampton G.M. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 61:2001;5974-5978.
19. Pettaway C.A., Pathak S., Greene G., Ramirez E., Wilson M.R., Killion J.J., Fidler I.J. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin. Cancer Res. 2:1996;1627-1636.
20. Fleming I.D., Cooper J.S., Henson D.E., Hutter R.V.P., Kennedy B.J., Murphy G.P., O'Sullivan B., Sobin L.H., Yarbro J.W. AJCC Cancer Staining Manual. fifth edition:1997;1-294 Lippincot Williams and Wilkins, Philadelphia.
21. Batra S.K., Kern H.F., Worlock A.J., Metzgar R.S., Hollingsworth M.A. Transfection of the human Muc 1 mucin gene into a poorly differentiated human pancreatic tumor cell line, Panc1: integration, expression and ultrastructural changes. J. Cell Sci. 100:1991;841-849.
22. Fairlie W.D., Moore A.G., Bauskin A.R., Russell P.K., Zhang H.P., Breit S.N. MIC-1 is a novel TGF-. rbeta superfamily cytokine associated with macrophage activation J. Leukoc. Biol. 65:1999;2-5.
23. Garcia-Arenas R., Lin F.F., Lin D., Jin L.P., Shih C.C., Chang C., Lin M.F. The expression of prostatic acid phosphatase is transcriptionally regulated in human prostate carcinoma cells. Mol. Cell Endocrinol. 111:1995;29-37.
24. Lin D.L., Whitney M.C., Yao Z., Keller E.T. Interleukin-6 induces androgen responsiveness in prostate cancer cells through up-regulation of androgen receptor expression. Clin. Cancer Res. 7:2001;1773-1781.
25. Culig Z., Klocker H., Bartsch G., Hobisch A. Androgen receptors in prostate cancer. Endocr. Relat. Cancer. 9:2002;155-170.
26. Feldman B.J., Feldman D. The development of androgen-independent prostate cancer. Nat. Rev. Cancer. 1:2001;34-45.
27. Grossmann M.E., Huang H., Tindall D.J. Androgen receptor signaling in androgen-refractory prostate cancer. J. Natl. Cancer Inst. 93:2001;1687-1697.
28. Barrack E.R. TGF β in prostate cancer: a growth inhibitor that can enhance tumorigenicity. Prostate. 31:1997;61-70.